Stratification of Patients With Interstitial Cystitis/Bladder Pain Syndrome According to the Anatomical Bladder Capacity

Mazeaud, Charles; Rigaud, J.; Levesque, Amélie; Madec, F.-X.; Clerc, Q. Le; Wack, Maxime; Normand, L. Le; Riant, T.; Verbe, M. Perrouin

doi:10.1016/j.urology.2018.07.046

Cited by 10 publications

(5 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is a matter of debate what is the underlying mechanism of the extremely low‐volume FS in IBS without DO, and whether this has a different pathophysiology from DO. Reported underlying pathologies of IBS without DO have included mild interstitial cystitis, depression/anxiety and neurologic diseases that affect the sensory pathway or the basal ganglia . Among neurologic diseases, myelopathies are reported to be the most common cause of IBS without DO .…”

Section: Discussionmentioning

confidence: 99%

“…The underlying pathology of IBS without DO may include alteration of the bladder afferent, alteration of the urethra, or both . The underlying pathology of IBS without DO is also a matter of debate, but appears to include mild interstitial cystitis, depression/anxiety and neurologic diseases that affect the sensory pathway or the basal ganglia, and so on. Among these, we present our data focusing on the urodynamic nature of IBS without DO, applying our five‐grade sensory measure during urodynamics …”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Increased bladder sensation without detrusor overactivity revisited: Use of a five‐grade sensory measure

Tateno

Sakakibara

Aiba

et al. 2019

LUTS

View full text Add to dashboard Cite

Aims: Increased bladder sensation (IBS) without detrusor overactivity (DO) is still a matter of debate, regarding its clinical relevance, urodynamic nature, underlying pathology, and management. Among these, we present our data focusing on the urodynamic nature of IBS without DO, by applying our five-grade sensory measure during urodynamics. Methods:We enrolled 400 individuals who visited our laboratory for screening of lower urinary tract function, mostly with neurogenic etiologies. They included 74 control, 87 DO (irrespective of IBS), and 239 IBS (defined as first sensation <100 mL) without DO. During slow bladder filling, we instructed individuals to indicate their sensation in five grades: 1, first sensation to 5, strong desire to void. We also instructed individuals to report other sensations such as pain.Results: The five-grade measure could be performed in all participants without difficulty. None of the participants reported pain or any qualitatively different sensations.Although we defined DO irrespective of IBS, the sensation interval 0 (start) to 1 (first sensation) of subjects with IBS but without DO was significantly less than that of subjects with DO (P < 0.05). Conclusions:The present study results showed that first sensation of subjects with IBS without DO was significantly less than that of subjects with DO (P < 0.05), while the bladder capacities of the two groups were the same. An extremely low-volume first sensation may suggest the possibility of IBS without DO. K E Y W O R D S bladder filling phase, increased bladder sensation without detrusor overactivity, overactive bladder syndrome, urodynamics

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Increased bladder sensation without detrusor overactivity revisited: Use of a five‐grade sensory measure

Tateno

Sakakibara

Aiba

et al. 2019

LUTS

View full text Add to dashboard Cite

show abstract

“…Co-morbidities are common, especially "functional" disorders such as irritable bowel syndrome and fibromyalgia 10,40 . Some have suggested that the presence of such chronic overlapping pain conditions should be the basis for separation of the IC population into subgroups which are bladder-centric (pain more localized to regions in or near the bladder) 50 and non-bladder-centric (or bladder-plus other) groups in which pain may be widespread 44,46 including a group with multiple morbidities who are polysymptomatic and polysyndromic 47 . Brain imaging studies, psychophysical testing and cystoscopic findings support the stratification of the IC population into subgroups 24,41,83,90,101 .…”

Section: The Disease To Be Modelled: Interstitial Cystitis (Ic)mentioning

confidence: 99%

Neuroplastic Changes in Adult Urogenital Sensation Induced by Neonatal Cystitis – A Review of Studies and Filling of Gaps

Ness,

DeWitte

2024

Preprint

View full text Add to dashboard Cite

Research studies related to neuroplastic changes that occur secondary to a bout of cystitis at a critical neonatal period of development in female rats (P14-16) are reviewed. They reveal that neonatal bladder inflammation (NBI) leads to an adult phenotype with many of the features of the human disorder, interstitial cystitis. Neurochemical, behavioral and neurophysiological differences between rats which experienced NBI and control animals are discussed and new data presented.

show abstract

“…These molecular and clinical data supported the framework for differing phenotypes of IC/BPS: a low bladder capacity subtype with bladder-centric disease and a nonlow bladder capacity subtype with generalized pain and psychosomatic disease. Furthermore, previous studies have shown that IC/BPS patients with low bladder capacity were older and had higher levels of frequency and nocturia, higher levels of acute and chronic bladder inflammation, earlier onset of painful urge during bladder filling, and poorer compliance [ 107 , 108 ].…”

Section: Clinical Diagnosis For Ic/bpsmentioning

confidence: 99%

Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome

Lin

Chuang

et al. 2021

Diagnostics

View full text Add to dashboard Cite

Interstitial cystitis/bladder pain syndrome (IC/BPS) is defined as a chronic bladder disorder with suprapubic pain (pelvic pain) and pressure and/or discomfort related to bladder filling accompanied by lower urinary tract symptoms, such as urinary frequency and urgency without urinary tract infection (UTI) lasting for at least 6 weeks. IC/BPS presents significant bladder pain and frequency urgency symptoms with unknown etiology, and it is without a widely accepted standard in diagnosis. Patients’ pathological features through cystoscopy and histologic features of bladder biopsy determine the presence or absence of Hunner lesions. IC/PBS is categorized into Hunner (ulcerative) type IC/BPS (HIC/BPS) or non-Hunner (nonulcerative) type IC/BPS (NHIC/BPS). The pathophysiology of IC/BPS is composed of multiple possible factors, such as chronic inflammation, autoimmune disorders, neurogenic hyperactivity, urothelial defects, abnormal angiogenesis, oxidative stress, and exogenous urine substances, which play a crucial role in the pathophysiology of IC/BPS. Abnormal expressions of several urine and serum specimens, including growth factor, methylhistamine, glycoprotein, chemokine and cytokines, might be useful as biomarkers for IC/BPS diagnosis. Further studies to identify the key molecules in IC/BPS will help to improve the efficacy of treatment and identify biomarkers of the disease. In this review, we discuss the potential medical therapy and assessment of therapeutic outcome with urinary biomarkers for IC/BPS.

show abstract

Stratification of Patients With Interstitial Cystitis/Bladder Pain Syndrome According to the Anatomical Bladder Capacity

Cited by 10 publications

References 21 publications

Increased bladder sensation without detrusor overactivity revisited: Use of a five‐grade sensory measure

Increased bladder sensation without detrusor overactivity revisited: Use of a five‐grade sensory measure

Neuroplastic Changes in Adult Urogenital Sensation Induced by Neonatal Cystitis – A Review of Studies and Filling of Gaps

Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome

Contact Info

Product

Resources

About